Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

A recent Nature Biotechnology article notes that less than 1% of the nearly 200 senior-level positions on investment teams include talent from underrepresented racial and ethnic groups. BIO’s commitment to increase diverse leadership in executive positions and corporate board rooms requires the biotechnology industry to explore the practices at companies, public policy, and the role of investors. Attend this session to learn more about legislation, corporate governance changes, and best practices from investors, board members, and executives